Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
49.56
-0.16 (-0.32%)
Feb 20, 2026, 4:00 PM EST - Market closed
Dianthus Therapeutics Revenue
Dianthus Therapeutics had revenue of $396.00K in the quarter ending September 30, 2025, a decrease of -81.77%. This brings the company's revenue in the last twelve months to $3.08M, down -42.64% year-over-year. In the year 2024, Dianthus Therapeutics had annual revenue of $6.24M with 120.63% growth.
Revenue (ttm)
$3.08M
Revenue Growth
-42.64%
P/S Ratio
695.95
Revenue / Employee
$39,462
Employees
78
Market Cap
2.14B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6.24M | 3.41M | 120.63% |
| Dec 31, 2023 | 2.83M | -3.59M | -55.96% |
| Dec 31, 2022 | 6.42M | 4.94M | 334.76% |
| Dec 31, 2021 | 1.48M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionDNTH News
- 4 days ago - Dianthus Therapeutics, Inc. (DNTH) Presents at Guggenheim Securities Emerging Outlook: Biotech Summit 2026 Transcript - Seeking Alpha
- 15 days ago - Dianthus Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 - GlobeNewsWire
- 5 weeks ago - Dianthus Therapeutics, Inc. (DNTH) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 6 weeks ago - Dianthus Therapeutics To Participate in the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 2 months ago - Leads Biolabs And Dianthus Therapeutics Announce Initiation of Phase 1 Trial Of LBL-047 (DNTH212) In Healthy Volunteers and Patients With Systemic Lupus Erythematosus (SLE) - GlobeNewsWire
- 3 months ago - Dianthus Therapeutics To Participate in the 8th Annual Evercore Healthcare Conference - GlobeNewsWire
- 3 months ago - Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q3 Financial Results - GlobeNewsWire
- 3 months ago - Dianthus Therapeutics to Participate in Four Investor Conferences During November - GlobeNewsWire